Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04316481 · ClinicalTrials.gov registry record · NA
IDE-ALERTS Continued Access Study
A NA study, sponsored by Angel Medical Systems.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04316481 is a NA study that was terminated before completion, run by Angel Medical Systems. The registered enrollment target is 17 participants.
The verdict
NCT04316481, a NA study, was terminated before completion, sponsored by Angel Medical Systems.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This Continued Access IDE Study includes a subset of former ALERTS trial (NCT00781118) patients and provides performance data for a refined Guardian implantable medical device (AMSG3-E) with a new battery designed to extend device longevity.
Interventions
- DEVICE AngelMed Guardian System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04316481
The ClinicalTrials.gov registry entry for NCT04316481 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angel Medical Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AngelMed Guardian System is the first listed.
NCT04316481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04316481 about?
NCT04316481 is a clinical study titled "IDE-ALERTS Continued Access Study". This Continued Access IDE Study includes a subset of former ALERTS trial (NCT00781118) patients and provides performance data for a refined Guardian implantable medical device (AMSG3-E) with a new battery designed to extend device longevity.
What is the current status of trial NCT04316481?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2020-09-22. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT04316481?
The interventions under investigation include: AngelMed Guardian System (DEVICE).
Who is sponsoring clinical trial NCT04316481?
This trial is sponsored by Angel Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.